Applied DNA Accepted into U.S. FDA’s Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging
FDA’s Physical-Chemical Identifier Guidance and 1-1 Interaction Will Guide Use of SigNature® Platform in Counterfeit-Risk Mitigation, Brand/IP Protection and Supply Chain
Read more